Cytokine-induced Neurogenesis for Alzheimer's Disease and Frontotemporal Dementia

T. Shirasawa, Luis Carlos Aguilar Cobos
{"title":"Cytokine-induced Neurogenesis for Alzheimer's Disease and Frontotemporal Dementia","authors":"T. Shirasawa, Luis Carlos Aguilar Cobos","doi":"10.46459/pmu.2022006","DOIUrl":null,"url":null,"abstract":": Alzheimer’s disease (AD) and frontotemporal dementia (FTD) are two major causes of dementia. These diseases are both progressive neurodegenerative diseases whereas no curative treatment has not yet been established. Regenerative approaches have been extensively researched for AD and FTD, but they are still in early phase of pre-clinical trials. We show here, for the first time, that cytokines such as hepatocyte growth factor (HGF), granulocyte colony stimulating factor (GCSF), insulin-like growth factors (IGFs), and progranulin (PGRN) can induce the neurogenesis of GABAergic and glutamatergic neurons in cerebral cortex and hippocampi of AD and FTD patients. We also showed the evidence, for the first time, that the atrophied hippocampi were significantly regenerated by cytokine-induced neurogenesis in AD and FTD patients, which was confirmed by MRI study and neurophysiological evaluations. We therefore explored the potentiality of cytokine cocktail treatment for AD and FTD and showed that cytokine-induced neurogenesis is a novel promising strategy to cure AD and FTD.","PeriodicalId":101009,"journal":{"name":"Personalized Medicine Universe","volume":"84 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Personalized Medicine Universe","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46459/pmu.2022006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

: Alzheimer’s disease (AD) and frontotemporal dementia (FTD) are two major causes of dementia. These diseases are both progressive neurodegenerative diseases whereas no curative treatment has not yet been established. Regenerative approaches have been extensively researched for AD and FTD, but they are still in early phase of pre-clinical trials. We show here, for the first time, that cytokines such as hepatocyte growth factor (HGF), granulocyte colony stimulating factor (GCSF), insulin-like growth factors (IGFs), and progranulin (PGRN) can induce the neurogenesis of GABAergic and glutamatergic neurons in cerebral cortex and hippocampi of AD and FTD patients. We also showed the evidence, for the first time, that the atrophied hippocampi were significantly regenerated by cytokine-induced neurogenesis in AD and FTD patients, which was confirmed by MRI study and neurophysiological evaluations. We therefore explored the potentiality of cytokine cocktail treatment for AD and FTD and showed that cytokine-induced neurogenesis is a novel promising strategy to cure AD and FTD.
细胞因子诱导的阿尔茨海默病和额颞叶痴呆的神经发生
阿尔茨海默病(AD)和额颞叶痴呆(FTD)是痴呆的两个主要原因。这两种疾病都是进行性神经退行性疾病,目前还没有有效的治疗方法。再生治疗AD和FTD的方法已被广泛研究,但仍处于临床前试验的早期阶段。本研究首次发现肝细胞生长因子(HGF)、粒细胞集落刺激因子(GCSF)、胰岛素样生长因子(IGFs)和前颗粒蛋白(PGRN)等细胞因子可诱导AD和FTD患者大脑皮层和海马gaba能和谷氨酸能神经元的神经发生。我们还首次发现,在AD和FTD患者中,细胞因子诱导的神经发生显著地再生了萎缩的海马,这一点通过MRI研究和神经生理学评估得到了证实。因此,我们探索了细胞因子混合治疗AD和FTD的潜力,并表明细胞因子诱导的神经发生是治疗AD和FTD的一种新的有希望的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信